CD36 and diabetes mellitus: In conclusion, STAMP2 gene overexpression significantly downregulated the angiogenesis of EWAT and BAT via the PPARγ/CD36 signalling pathway, contributing to the improvement of IR and providing a new treatment target for diabetes and related diseases.